| abstract |
Methods, compounds, compositions, and kits for the treatment of cancer, comprising TLR2 agonists, particularly di-palmitoyl-S-glyceryl-cysteine (Pam2Cys) derivatives and conjugates, are provided. In one aspect, methods of treating, preventing or minimizing the progression of cancer comprising the administration of a compound comprising a Pam2Cys moiety and a polyethylene glycol (PEG) are provided. |